Rizatriptan Benzoate Tablet
Product Images NDC 67877-261

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 67877-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rizatriptan 10mg 100

Each tablet contains 14.53 mg of rizatriptan benzoate, which is equivalent to 10 g of rizatriptan. This medication is used to treat migraines. The usual adult dosage is not provided, and the reader should refer to the accompanying circular. The tablet should be stored in a temperature range of 20° to 25°C and dispensed in a light-resistant container. The tablets come in a quantity of 100 and are distributed by Ascend Laboratories, LLC. The product is manufactured by Akem Laboratories Ltd. The remaining text appears to be related to specific labeling instructions and is not informative.*

FDA Label Image

Rizatriptan 10mg 18

Rizatriptan Benzoate is a prescription medication available in tablet form. The package contains 18.8 x 6 unit dose tablets that are not child-resistant. The usual dose for adults is stated as 2-10 mg, according to the USP guidelines. However, the rest of the text is not readable due to errors.*

FDA Label Image

Rizatriptan 5mg 12

This is a medication called Rizatriptan Benzoate that comes in a package of 12 tablets. The tablets are not child-resistant. The recommended adult dosage is not clear from the text. The rest of the text seems to be garbled or misread by the , so it's not available for understanding.*

FDA Label Image

Rizatriptan 5mg 30

FDA Label Image

Rizatriptan Fig 1

This is a chart displaying the probability of response to different doses of Rizatriptan Benzoate and Placebo over time post-dose. The doses include Rizatriptan Benzoate 5mg and Rizatriptan Benzoate 10mg. However, no further context is available to determine the purpose or significance of this chart.*

FDA Label Image

Rizatriptan Fig 2

This appears to be a chart displaying the estimated probability of remedication or rescue after taking different doses of Rizatriptan Benzoate (5mg and 10mg). The chart also shows the time post-dose in hours.*

FDA Label Image

Rizatriptan Fig 5

FDA Label Image

Rizatriptan Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.